Gaburjakova J, Gaburjakova M
Int J Mol Sci. 2023; 24(6).
PMID: 36982484
PMC: 10049336.
DOI: 10.3390/ijms24065409.
Thippeswamy R, Shetty S
Anesth Essays Res. 2019; 12(4):778-785.
PMID: 30662107
PMC: 6319054.
DOI: 10.4103/aer.AER_111_18.
Arimura H, Hoka S, Bosnjak Z, Kampine J
J Anesth. 2017; 8(4):467-471.
PMID: 28921357
DOI: 10.1007/BF02514628.
Ohwada T, Oka T, Kohchi A, Inaba H, Iijima K, Mizuguchi T
J Anesth. 2013; 8(3):339-43.
PMID: 23568124
DOI: 10.1007/BF02514662.
Kasuda H, Akazawa S, Shimizu R
J Anesth. 1990; 4(4):295-302.
PMID: 15235959
DOI: 10.1007/s0054000040295.
Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review.
Delgado-Herrera L, Ostroff R, Rogers S
CNS Drug Rev. 2001; 7(1):48-120.
PMID: 11420572
PMC: 6741648.
DOI: 10.1111/j.1527-3458.2001.tb00190.x.
Comparative tolerability profiles of the inhaled anaesthetics.
Fee J, Thompson G
Drug Saf. 1997; 16(3):157-70.
PMID: 9098654
DOI: 10.2165/00002018-199716030-00002.
Antiarrhythmic action of rilmenidine on adrenaline-induced arrhythmia via central imidazoline receptors in halothane-anaesthetized dogs.
Mammoto T, Kamibayashi T, Hayashi Y, Yamatodani A, Takada K, Yoshiya I
Br J Pharmacol. 1996; 117(8):1744-8.
PMID: 8732285
PMC: 1909557.
DOI: 10.1111/j.1476-5381.1996.tb15348.x.
Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.
Patel S, Goa K
Drugs. 1996; 51(4):658-700.
PMID: 8706599
DOI: 10.2165/00003495-199651040-00009.
Cardiac electrophysiology and conduction pathway ablation.
Renwick J, Kerr C, McTaggart R, Yeung J
Can J Anaesth. 1993; 40(11):1053-64.
PMID: 8269567
DOI: 10.1007/BF03009477.
Comparison of haemodynamic changes induced by sevoflurane and halothane in paediatric patients.
Kawana S, Wachi J, Nakayama M, Namiki A
Can J Anaesth. 1995; 42(7):603-7.
PMID: 7553996
DOI: 10.1007/BF03011877.
The effect of acute elevation of blood pressure on myocardial performance during enflurane and enflurane with nitrous oxide anaesthesia in man.
Duke P, Morton M, Trosky S
Can Anaesth Soc J. 1982; 29(2):130-5.
PMID: 7066737
DOI: 10.1007/BF03007991.
Modification by halogenated anaesthetics of chronotropic response during reversal of neuromuscular blockade.
Samra S, Pandit U, Pandit S, Kothary S
Can Anaesth Soc J. 1983; 30(1):48-52.
PMID: 6824987
DOI: 10.1007/BF03007716.
Cardiovascular physiology: venous return.
Thomson I
Can Anaesth Soc J. 1984; 31(3 Pt 2):S31-7.
PMID: 6722631
DOI: 10.1007/BF03007033.
Nitrous oxide added to halothane reduces coronary flow and myocardial oxygen consumption in patients with coronary disease.
MOFFITT E, Sethna D, Gary R, Raymond M, Matloff J, Bussell J
Can Anaesth Soc J. 1983; 30(1):5-9.
PMID: 6600645
DOI: 10.1007/BF03007709.
Anesthesia for intracranial vascular malformations.
Frost E
Bull N Y Acad Med. 1984; 60(7):759-68.
PMID: 6386085
PMC: 1911717.
Pacemaker migration and sinus node arrest with methoxyflurane and halothane.
REYNOLDS A, Chiz J, PASQUET A
Can Anaesth Soc J. 1971; 18(2):137-44.
PMID: 5572697
DOI: 10.1007/BF03025442.
The use of the electrical-impedance technique for the monitoring of cardiac output and limb bloodflow during anaesthesia.
Hill D, Lowe H
Med Biol Eng. 1973; 11(5):534-45.
PMID: 4788880
DOI: 10.1007/BF02477397.
The cardiovascular and respiratory effects of isoflurane-nitrous oxide anaesthesia.
Dolan W, STEVENS W, Eger EI I, Cromwell T, Halsey M, Shakespeare T
Can Anaesth Soc J. 1974; 21(6):557-68.
PMID: 4462956
DOI: 10.1007/BF03006017.
Electroretinographic responses to the addition of nitrous oxide to halothane in rats.
Wasserschaff M, Schmidt J
Doc Ophthalmol. 1986; 64(4):347-54.
PMID: 3652909
DOI: 10.1007/BF00212058.
